pharma is the sole category represented across all 2 tracked stories. Bilal Cassim is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. The 12-day window averages about 1.2 stories each week. Source depth averages 2 original sources per story, versus 3.6 across the same-window beat baseline.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Medicinal Cannabis
pharma is the sole category represented across all 2 tracked stories. Bilal Cassim is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. The 12-day window averages about 1.2 stories each week. Source depth averages 2 original sources per story, versus 3.6 across the same-window beat baseline. The 5.5 average consequence score is below the beat benchmark of 6.1 in the same window. This profile follows 2 Biotech stories mentioning Medicinal Cannabis across the period from March 9, 2026 to March 20, 2026.
Stories tracked
2
Per week
1.2
Sources per story
2
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 192 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Medicinal Cannabis. Shared-story counts are live from our verified record — not editorial picks.
Bilal Cassim’s public testimony regarding the efficacy of medicinal cannabis for PTSD and sleep disorders highlights a growing trend of patient-led advocacy in Australia. This case underscores the shifting clinical landscape as researchers and regulators grapple with the integration of cannabinoid therapies into standard psychiatric care.
The New South Wales Government has signaled a major policy shift by proposing to legalize driving for medicinal cannabis users who have THC in their system. This move aims to transition from a zero-tolerance 'presence' model to an 'impairment-based' framework for legal patients.
Medicinal Cannabis is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.